Published in Hepatitis Weekly, September 18th, 1995
The company said it plans to conduct additional scale-up work in 1995 and to file an Investigational New Drug Application early in 1996.
In May 1995, researchers at the New York Blood Center, New York University (NYU) Medical Center and the Weizmann Institute in Israel published a paper in the journal Transfusion, which showed that HIV and other viruses present in donated blood are destroyed by hypericin, a naturally occurring compound with strong antiviral activity....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1995-09-18)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.